Concepedia

Ashley Orillion

AO

Statistics

Publications

13

Citations

1.1K

H-Index

12

Active since

2014

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Indiana University Health

Indiana University – Purdue University Indianapolis

Indiana Cancer Consortium

University of Turin

Ashley Orillion is an author at Roswell Park Comprehensive Cancer Center specializing in oncology, medicine, and renal cell carcinoma.

ORCID

Publications per year

2014–2020

13

Publications

13

Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma

Ashley Orillion, Ayumi Hashimoto, Nur P. Damayanti et al. · Clinical Cancer Research · 2017 · 364 citations · Full text

, , +17

Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy

Ashley Orillion, Nur P. Damayanti, Li Shen et al. · Clinical Cancer Research · 2018 · 113 citations · Full text

, , +17

PTPN14 Forms a Complex with Kibra and LATS1 Proteins and Negatively Regulates the YAP Oncogenic Function

Kayla E. Wilson, Yingwei Li, Nuo Yang et al. · Journal of Biological Chemistry · 2014 · 94 citations · Full text

, , +17

Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870)

David I. Quinn, Hans J. Hammers, Paul Monk et al. · Clinical Cancer Research · 2017 · 94 citations

, , +17

Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma

Nur P. Damayanti, Justin A. Budka, Heba Khella et al. · Clinical Cancer Research · 2018 · 94 citations

, , +13

1–5 of 13